Regeneron Pharmaceuticals (NASDAQ:REGN) Reaches New 52-Week Low on Analyst Downgrade
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) shares reached a new 52-week low on Thursday after UBS Group lowered their price target on the stock from $633.00 to $560.00. UBS Group currently has a neutral rating on the stock. Regeneron Pharmaceuticals traded as low as $476.49 and last traded at $483.19, with a volume […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) shares reached a new 52-week low on Thursday after UBS Group lowered their price target on the stock from $633.00 to $560.00. UBS Group currently has a neutral rating on the stock. Regeneron Pharmaceuticals traded as low as $476.49 and last traded at $483.19, with a volume […]
